1013 related articles for article (PubMed ID: 24557838)
1. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
Lucifora J; Xia Y; Reisinger F; Zhang K; Stadler D; Cheng X; Sprinzl MF; Koppensteiner H; Makowska Z; Volz T; Remouchamps C; Chou WM; Thasler WE; Hüser N; Durantel D; Liang TJ; Münk C; Heim MH; Browning JL; Dejardin E; Dandri M; Schindler M; Heikenwalder M; Protzer U
Science; 2014 Mar; 343(6176):1221-8. PubMed ID: 24557838
[TBL] [Abstract][Full Text] [Related]
2. Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".
Xia Y; Lucifora J; Reisinger F; Heikenwalder M; Protzer U
Science; 2014 Jun; 344(6189):1237. PubMed ID: 24926011
[TBL] [Abstract][Full Text] [Related]
3. Virology. Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".
Chisari FV; Mason WS; Seeger C
Science; 2014 Jun; 344(6189):1237. PubMed ID: 24926010
[TBL] [Abstract][Full Text] [Related]
4. Cytidine deamination and cccDNA degradation: A new approach for curing HBV?
Ding S; Robek MD
Hepatology; 2014 Dec; 60(6):2118-21. PubMed ID: 25142126
[No Abstract] [Full Text] [Related]
5. Virology. Getting rid of a persistent troublemaker to cure hepatitis.
Shlomai A; Rice CM
Science; 2014 Mar; 343(6176):1212-3. PubMed ID: 24626921
[No Abstract] [Full Text] [Related]
6. Comparative Analysis of the Antiviral Effects Mediated by Type I and III Interferons in Hepatitis B Virus-Infected Hepatocytes.
Bockmann JH; Stadler D; Xia Y; Ko C; Wettengel JM; Schulze Zur Wiesch J; Dandri M; Protzer U
J Infect Dis; 2019 Jul; 220(4):567-577. PubMed ID: 30923817
[TBL] [Abstract][Full Text] [Related]
7. TGF-β triggers HBV cccDNA degradation through AID-dependent deamination.
Qiao Y; Han X; Guan G; Wu N; Sun J; Pak V; Liang G
FEBS Lett; 2016 Feb; 590(3):419-27. PubMed ID: 26867650
[TBL] [Abstract][Full Text] [Related]
8. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus covalently closed circular DNA homeostasis is independent of the lymphotoxin pathway during chronic HBV infection.
Meier MA; Suslov A; Ketterer S; Heim MH; Wieland SF
J Viral Hepat; 2017 Aug; 24(8):662-671. PubMed ID: 28182305
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-Inducible Factor 1 Alpha-Mediated RelB/APOBEC3B Down-regulation Allows Hepatitis B Virus Persistence.
Riedl T; Faure-Dupuy S; Rolland M; Schuehle S; Hizir Z; Calderazzo S; Zhuang X; Wettengel J; Lopez MA; Barnault R; Mirakaj V; Prokosch S; Heide D; Leuchtenberger C; Schneider M; Heßling B; Stottmeier B; Wessbecher IM; Schirmacher P; McKeating JA; Protzer U; Durantel D; Lucifora J; Dejardin E; Heikenwalder M
Hepatology; 2021 Oct; 74(4):1766-1781. PubMed ID: 33991110
[TBL] [Abstract][Full Text] [Related]
11. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection.
Hofmann S; Luther J; Plank V; Oswald A; Mai J; Simons I; Miller J; Falcone V; Hansen-Palmus L; Hengel H; Nassal M; Protzer U; Schreiner S
Microbiol Spectr; 2024 May; 12(5):e0378823. PubMed ID: 38567974
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
[TBL] [Abstract][Full Text] [Related]
14. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
[TBL] [Abstract][Full Text] [Related]
15. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
[TBL] [Abstract][Full Text] [Related]
16. Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20.
Stadler D; Kächele M; Jones AN; Hess J; Urban C; Schneider J; Xia Y; Oswald A; Nebioglu F; Bester R; Lasitschka F; Ringelhan M; Ko C; Chou WM; Geerlof A; van de Klundert MA; Wettengel JM; Schirmacher P; Heikenwälder M; Schreiner S; Bartenschlager R; Pichlmair A; Sattler M; Unger K; Protzer U
EMBO Rep; 2021 Jun; 22(6):e49568. PubMed ID: 33969602
[TBL] [Abstract][Full Text] [Related]
17. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
Xia Y; Stadler D; Lucifora J; Reisinger F; Webb D; Hösel M; Michler T; Wisskirchen K; Cheng X; Zhang K; Chou WM; Wettengel JM; Malo A; Bohne F; Hoffmann D; Eyer F; Thimme R; Falk CS; Thasler WE; Heikenwalder M; Protzer U
Gastroenterology; 2016 Jan; 150(1):194-205. PubMed ID: 26416327
[TBL] [Abstract][Full Text] [Related]
18. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Sheraz M; Cheng J; Tang L; Chang J; Guo JT
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
[TBL] [Abstract][Full Text] [Related]
19. Distribution of Hepatitis B Virus Nuclear DNA.
Li M; Sohn JA; Seeger C
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046450
[TBL] [Abstract][Full Text] [Related]
20. Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line.
Ogura N; Watashi K; Noguchi T; Wakita T
Biochem Biophys Res Commun; 2014 Sep; 452(3):315-21. PubMed ID: 25150444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
